The drug tirzepatide (Mounjaro) was created and found to work as a dual GLP-1-GIP agonist, with trials suggesting that it could reduce body weight by more than 20 per cent
A.BergmanA.StevensC.KoteyP.YiB.ZhaoP.et al (2006a)
However, consult your gastroenterologist if youre taking a GLP-1 medication and experiencing persistent digestive issues
What if a new process was possibleone that would eliminate hazardous solvents, reduce amino acid reaction times, and open the door to a simpler, more scalable manufacturing lifecycle overall
Signs your peptide has degraded Watch for these warning signs after reconstitution: Cloudiness that was not present immediately after mixing Particles floating in the solution Color change from clear to yellow, brown, or any other color Unusual smell (most peptide solutions are odorless or have a faint benzyl alcohol scent) Precipitate forming at the bottom of the vial If you notice any of these, discard the vial
Animal data only Scaling a mouse 5 mg/kg dose to a person involves large uncertainty
